COMMUNIQUÉ DE PRESSE publié le 16/06/2026 à 15:15, il y a 14 jours 2 heures Waterdrop Inc. Reports First Quarter 2026 Unaudited Financial Results, Q1 Net Revenue Up 64.8% Year-over-Year Waterdrop Inc. reports a 64.8% year-over-year increase in net revenue for Q1 2026, marking its 17th consecutive quarter of profitability. The company is committed to AI-powered innovation in healthcare and financial services Financial Results Healthcare Innovation AI-powered Technology Q1 2026 Waterdrop Inc.
COMMUNIQUÉ DE PRESSE publié le 16/06/2026 à 15:15, il y a 14 jours 2 heures Karbon-X Advances Large-Scale Senegal Blue Carbon Project as Second Globally Registered Under Verra's VM0033 Methodology Karbon-X announces Senegal Blue Carbon Mangrove Project registration under Verra's VCS and CCB Standards, highlighting environmental asset development and future market opportunities Karbon-X Climate Solutions Senegal Blue Carbon Verra Registration Environmental Assets
COMMUNIQUÉ DE PRESSE publié le 16/06/2026 à 15:07, il y a 14 jours 2 heures American Banker Bolsters Its AI Intelligence Platform with Hire of Research Veteran Larry Cao New York, United States, June 16th, 2026, FinanceWire
COMMUNIQUÉ DE PRESSE publié le 16/06/2026 à 15:05, il y a 14 jours 2 heures Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc The Vanguard Group, Inc. discloses 4.74% stake in Tate & Lyle plc on 15 June 2026. Purchase of 92 securities at 5.67 GBP per unit disclosed The Vanguard Group, Inc. Stake Disclosure Securities Purchase Tate & Lyle Plc GBP 5.67
COMMUNIQUÉ DE PRESSE publié le 16/06/2026 à 15:05, il y a 14 jours 2 heures Your Prime Moment to Save: Aurzen Unveils Amazon Prime Day 2026 Deals Aurzen announces Amazon Prime Day 2026 deals for its smart projector lineup, offering discounted prices and premium viewing experiences for sports fans and entertainment seekers Entertainment Discounts Aurzen Smart Projectors Amazon Prime Day 2026
COMMUNIQUÉ DE PRESSE publié le 16/06/2026 à 15:02, il y a 14 jours 2 heures Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses 3.59% stake in Spire Healthcare Group plc on 15 June 2026. Details in Form 8.3 according to Takeover Code Form 8.3 The Vanguard Group Takeover Code Stake Disclosure Spire Healthcare Group Plc
COMMUNIQUÉ DE PRESSE publié le 16/06/2026 à 15:00, il y a 14 jours 2 heures BlackBerry Answers Rising Demand for Sovereign Endpoint Control BlackBerry UEM enhances AI-assisted operations, post-quantum readiness, macOS support for enterprise, defense, and governments. Sovereign endpoint control expanded for data residency and cloud independence UEM BlackBerry Post-quantum Readiness AI-assisted Operations MacOS Support
COMMUNIQUÉ DE PRESSE publié le 16/06/2026 à 14:59, il y a 14 jours 2 heures Form 8.3 - The Vanguard Group, Inc.: Senior plc The Vanguard Group, Inc. discloses a 5.13% ownership in Senior plc as of 15 June 2026. Details on securities and transactions provided in Form 8.3 disclosure The Vanguard Group, Inc. Form 8.3 Ownership Disclosure Securities Transactions Senior Plc
COMMUNIQUÉ DE PRESSE publié le 16/06/2026 à 14:58, il y a 14 jours 2 heures Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses 2.57% ownership in Schroders plc. Form 8.3 public disclosure of relevant securities holdings Form 8.3 Schroders Plc Vanguard Group Ownership Disclosure Securities Holdings
COMMUNIQUÉ DE PRESSE publié le 16/06/2026 à 14:58, il y a 14 jours 2 heures Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited The Vanguard Group, Inc. discloses a 5.05% interest in Picton Property Income Limited as of 15 June 2026. They made purchases and sales of relevant securities Sales The Vanguard Group, Inc. Purchases Interests Picton Property Income Limited
Publié le 30/06/2026 à 17:40, il y a 2 minutes Schneider Electric annonce un accord en vue d’acquérir Cognite, ouvrant une nouvelle ère d’intelligence stratégique pour l’IA industrielle
Publié le 30/06/2026 à 17:40, il y a 2 minutes Schneider Electric announces agreement to acquire Cognite, unlocking a new level of strategic intelligence for Industrial AI
Publié le 30/06/2026 à 15:06, il y a 2 heures 36 minutes 260630 BENETEAU Transactions sur actions propres
Publié le 30/06/2026 à 07:30, il y a 10 heures 12 minutes Gimv sells its stake in AlpenBlu Clinics (formerly Les Psy Réunis), a Swiss provider of outpatient mental healthcare, to Impact Healthcare.
Publié le 30/06/2026 à 07:30, il y a 10 heures 12 minutes Gimv cède sa participation dans AlpenBlu Clinics (précédemment Les Psy Réunis), acteur suisse des soins ambulatoires en santé mentale, à Impact Healthcare
Publié le 30/06/2026 à 15:00, il y a 2 heures 42 minutes Four Nines Gold Advances Toward Maiden Drill Program with Property-Wide Geophysical Survey at Hayden Hill
Publié le 30/06/2026 à 15:00, il y a 2 heures 42 minutes BlackBerry AtHoc Strengthens Enterprise Readiness as Cyber, Climate, and Geopolitical Uncertainty Rises
Publié le 30/06/2026 à 15:00, il y a 2 heures 42 minutes Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF)
Publié le 30/06/2026 à 14:30, il y a 3 heures 12 minutes NV Gold Announces Non-Brokered Private Placement
Publié le 30/06/2026 à 14:00, il y a 3 heures 42 minutes Datametrex Announces Completion of AI-Based Evaluation of 2 Patents and Launch of Licensing Initiative
Publié le 30/06/2026 à 17:36, il y a 6 minutes YESFLIX Medien GmbH und Your Family Entertainment AG vereinbaren strategische Kooperation
Publié le 30/06/2026 à 17:30, il y a 12 minutes Partners Group invests in Avenue Capital Group’s global commercial aviation leasing portfolio
Publié le 30/06/2026 à 16:34, il y a 1 heure 7 minutes hep global concludes fiscal year 2025 with a positive consolidated result
Publié le 30/06/2026 à 16:05, il y a 1 heure 37 minutes Selective PPARα Modulator "K-808" (Pemafibrate) Granted "Breakthrough Therapy" Designation by the U.S. Food and Drug Administration (FDA) As a Treatment for Primary Biliary Cholangitis